MANUFACTURING
BIOTECH INNOVATION
Scroll
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
Speed Up Your Research with Anemocyte Solution
Visit shop.anemocyte.com to discover more solution to streamline and speed-up your research
NEWS & EVENTS
Anemocyte to attend Advanced Therapies Usa 2025
We are excited to announce that Advanced Therapies USA 2025 (November 18-19, Philadelphia) will bring together the entire ecosystem of...
Anemocyte to Unveil Innovative Technology Platform at the 13th International mRNA Health Conference
Anemocyte Srl is set to make a significant contribution to the 13th International mRNA Health Conference in Berlin and online,...
Anemocyte Srl to attend TIDES Europe 2025 in Basel
Anemocyte will participate in TIDES Europe 2025, taking place in Basel, Switzerland, from 11 to 13 November 2025....
Genenta and Anemocyte announce strategic partnership to advance off-the-shelf LVV Plasmid DNA production
Genenta Science and ANEMOCYTE, today announced a strategic collaboration with a focus on off-the-shelf lentiviral vector (“LVV”) Plasmid DNA technology...
Anemocyte to exhibit at CPHI Frankfurt 2025 in the BioProduction Zone
Anemocyte is pleased to announce its participation in CPHI Europe 2025, taking place in Frankfurt, Germany, from October 28 to...
Anemocyte at BioJapan / Regenerative Medicine Japan / healthTECH Japan 2025
We are delighted to announce Anemocyte’s participation in BioJapan / Regenerative Medicine Japan / healthTECH Japan 2025, taking place from...
MANUFACTURING
BIOTECH
INNOVATION
PLASMID
Plasmid DNA development and manufacturing for viral vector and mRNA production
ANEMOCYTE MEANS TALENTS
Here at Anemocyte, we support, value and inspire those with a vision of a different world.
Speed Up Your Research with Anemocyte Solution
Visit shop.anemocyte.com to discover more solution to streamline and speed-up your research
NEWS & EVENTS
Anemocyte to attend Advanced Therapies Usa 2025
We are excited to announce that Advanced Therapies USA 2025 (November 18-19, Philadelphia) will bring together the entire ecosystem of...
Anemocyte to Unveil Innovative Technology Platform at the 13th International mRNA Health Conference
Anemocyte Srl is set to make a significant contribution to the 13th International mRNA Health Conference in Berlin and online,...
Anemocyte Srl to attend TIDES Europe 2025 in Basel
Anemocyte will participate in TIDES Europe 2025, taking place in Basel, Switzerland, from 11 to 13 November 2025....
Genenta and Anemocyte announce strategic partnership to advance off-the-shelf LVV Plasmid DNA production
Genenta Science and ANEMOCYTE, today announced a strategic collaboration with a focus on off-the-shelf lentiviral vector (“LVV”) Plasmid DNA technology...
Anemocyte to exhibit at CPHI Frankfurt 2025 in the BioProduction Zone
Anemocyte is pleased to announce its participation in CPHI Europe 2025, taking place in Frankfurt, Germany, from October 28 to...
Anemocyte at BioJapan / Regenerative Medicine Japan / healthTECH Japan 2025
We are delighted to announce Anemocyte’s participation in BioJapan / Regenerative Medicine Japan / healthTECH Japan 2025, taking place from...
